重新审视最佳实践指南和患者护理工作流程,以管理与药物相关的颌骨骨坏死风险:比较总结和案例研究。

IF 1.3 4区 医学 Q3 DENTISTRY, ORAL SURGERY & MEDICINE
Jen Chen, Chia-Yu Wu, Kristina Gallagher, Chin-Wei Wang
{"title":"重新审视最佳实践指南和患者护理工作流程,以管理与药物相关的颌骨骨坏死风险:比较总结和案例研究。","authors":"Jen Chen, Chia-Yu Wu, Kristina Gallagher, Chin-Wei Wang","doi":"10.3290/j.qi.b4213007","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Patients taking antiresorptive medications in dental clinics are at risk of medication-related osteonecrosis of the jaw (MRONJ), which poses daily challenges for their clinicians. This paper aimed to summarize and revisit the three most recognized practice guidelines for the management and prevention of MRONJ, which were proposed by the American Association of Oral and Maxillofacial Surgeons (AAOMS), and presented by the Journal of Bone and Mineral Research (JBMR) and the Journal of Clinical Oncology (JCO). Results and case studies: The AAOMS position paper focused on risk stratification by different medications, management decision trees, risk factors, pathophysiology, and disease staging. The JBMR international consensus presented eight focused questions, which were addressed by systematic reviews. The JCO clinical practice guideline presented six clinical questions, and each concluded with practical recommendations. Practical information was summarized and converted into an adoptable patient care workflow for clinicians to follow and apply in daily practice. Three case studies presented were treated following these guidelines. Each patient underwent advanced surgeries including alveoloplasty, tooth extraction, implant placement, and particulate bone grafting. Some of the considerations not fully informed were discussed and illustrated in each step of the patient care workflow, which included specifics for risk communication, updates on the use of antibiotics, biomarkers, and drug holidays.</p><p><strong>Conclusion and practical implications: </strong>Structured risk communication with official informed consent documentation should be considered before initiating invasive treatments. Disease control phase with home care therapy should be provided prior to staged reconstructive therapy. Drug holidays and antibiotics coverage can be customized based on individual conditions and related procedures with interprofessional coordination.</p>","PeriodicalId":20831,"journal":{"name":"Quintessence international","volume":"0 0","pages":"832-843"},"PeriodicalIF":1.3000,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Revisiting best practice guidelines and patient care workflow for managing the risk of medication-related osteonecrosis of the jaw: comparative summary and case studies.\",\"authors\":\"Jen Chen, Chia-Yu Wu, Kristina Gallagher, Chin-Wei Wang\",\"doi\":\"10.3290/j.qi.b4213007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Patients taking antiresorptive medications in dental clinics are at risk of medication-related osteonecrosis of the jaw (MRONJ), which poses daily challenges for their clinicians. This paper aimed to summarize and revisit the three most recognized practice guidelines for the management and prevention of MRONJ, which were proposed by the American Association of Oral and Maxillofacial Surgeons (AAOMS), and presented by the Journal of Bone and Mineral Research (JBMR) and the Journal of Clinical Oncology (JCO). Results and case studies: The AAOMS position paper focused on risk stratification by different medications, management decision trees, risk factors, pathophysiology, and disease staging. The JBMR international consensus presented eight focused questions, which were addressed by systematic reviews. The JCO clinical practice guideline presented six clinical questions, and each concluded with practical recommendations. Practical information was summarized and converted into an adoptable patient care workflow for clinicians to follow and apply in daily practice. Three case studies presented were treated following these guidelines. Each patient underwent advanced surgeries including alveoloplasty, tooth extraction, implant placement, and particulate bone grafting. Some of the considerations not fully informed were discussed and illustrated in each step of the patient care workflow, which included specifics for risk communication, updates on the use of antibiotics, biomarkers, and drug holidays.</p><p><strong>Conclusion and practical implications: </strong>Structured risk communication with official informed consent documentation should be considered before initiating invasive treatments. Disease control phase with home care therapy should be provided prior to staged reconstructive therapy. Drug holidays and antibiotics coverage can be customized based on individual conditions and related procedures with interprofessional coordination.</p>\",\"PeriodicalId\":20831,\"journal\":{\"name\":\"Quintessence international\",\"volume\":\"0 0\",\"pages\":\"832-843\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-11-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Quintessence international\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3290/j.qi.b4213007\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Quintessence international","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3290/j.qi.b4213007","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

目的:在牙科诊所服用抗吸收药物的患者存在药物相关性颌骨骨坏死(MRONJ)的风险,这给临床医生带来了日常挑战。本文旨在总结和回顾由美国口腔颌面外科医师协会(AAOMS)提出、《骨与矿物研究杂志》(JBMR)和《临床肿瘤学杂志》(JCO)发表的三个最受认可的MRONJ管理和预防实践指南。结果和案例研究:AAOMS的立场文件侧重于不同药物、管理决策树、危险因素、病理生理和疾病分期的风险分层。JBMR国际共识提出了八个重点问题,并通过系统评价加以解决。JCO临床实践指南提出了六个临床问题,每个问题最后都提出了实用的建议。总结实用信息并将其转化为临床医生在日常实践中遵循和应用的可采用的患者护理工作流程。提出的三个案例研究是按照这些指导方针处理的。每位患者都接受了先进的手术,包括牙槽成形术、拔牙、种植体植入和颗粒骨移植。在患者护理工作流程的每个步骤中,讨论和说明了一些未充分告知的注意事项,包括风险沟通的细节、抗生素使用的更新、生物标志物和药物假期。结论和实际意义:在开始侵入性治疗之前,应考虑与官方知情同意文件进行结构化风险沟通。疾病控制阶段的家庭护理治疗应在分期重建治疗之前提供。药物假期和抗生素覆盖范围可以根据个人情况和相关程序进行定制,并进行跨专业协调。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Revisiting best practice guidelines and patient care workflow for managing the risk of medication-related osteonecrosis of the jaw: comparative summary and case studies.

Objective: Patients taking antiresorptive medications in dental clinics are at risk of medication-related osteonecrosis of the jaw (MRONJ), which poses daily challenges for their clinicians. This paper aimed to summarize and revisit the three most recognized practice guidelines for the management and prevention of MRONJ, which were proposed by the American Association of Oral and Maxillofacial Surgeons (AAOMS), and presented by the Journal of Bone and Mineral Research (JBMR) and the Journal of Clinical Oncology (JCO). Results and case studies: The AAOMS position paper focused on risk stratification by different medications, management decision trees, risk factors, pathophysiology, and disease staging. The JBMR international consensus presented eight focused questions, which were addressed by systematic reviews. The JCO clinical practice guideline presented six clinical questions, and each concluded with practical recommendations. Practical information was summarized and converted into an adoptable patient care workflow for clinicians to follow and apply in daily practice. Three case studies presented were treated following these guidelines. Each patient underwent advanced surgeries including alveoloplasty, tooth extraction, implant placement, and particulate bone grafting. Some of the considerations not fully informed were discussed and illustrated in each step of the patient care workflow, which included specifics for risk communication, updates on the use of antibiotics, biomarkers, and drug holidays.

Conclusion and practical implications: Structured risk communication with official informed consent documentation should be considered before initiating invasive treatments. Disease control phase with home care therapy should be provided prior to staged reconstructive therapy. Drug holidays and antibiotics coverage can be customized based on individual conditions and related procedures with interprofessional coordination.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Quintessence international
Quintessence international 医学-牙科与口腔外科
CiteScore
3.30
自引率
5.30%
发文量
11
审稿时长
1 months
期刊介绍: QI has a new contemporary design but continues its time-honored tradition of serving the needs of the general practitioner with clinically relevant articles that are scientifically based. Dr Eli Eliav and his editorial board are dedicated to practitioners worldwide through the presentation of high-level research, useful clinical procedures, and educational short case reports and clinical notes. Rigorous but timely manuscript review is the first order of business in their quest to publish a high-quality selection of articles in the multiple specialties and disciplines that encompass dentistry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信